$1.07 Billion is the total value of Consonance Capital Management LP's 38 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 114.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $80,291,000 | – | 528,964 | +100.0% | 7.50% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $79,381,000 | – | 1,710,803 | +100.0% | 7.41% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $72,481,000 | – | 330,000 | +100.0% | 6.77% | – |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $71,268,000 | +132.3% | 584,885 | -61.3% | 6.66% | +78.1% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $69,348,000 | +14.2% | 3,532,738 | -24.6% | 6.48% | -12.4% |
| GNMK | Sell | GENMARK DIAGNOSTICS INC | $65,410,000 | -13.1% | 4,480,163 | -15.5% | 6.11% | -33.4% |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $64,797,000 | +125.5% | 893,499 | +48.2% | 6.05% | +72.9% |
| GMED | New | GLOBUS MED INCcl a | $59,282,000 | – | 908,953 | +100.0% | 5.54% | – |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $55,031,000 | +18.8% | 2,729,709 | +15.2% | 5.14% | -8.9% |
| MGNX | Sell | MACROGENICS INC | $52,574,000 | -44.3% | 2,299,829 | -38.6% | 4.91% | -57.3% |
| KROS | New | KEROS THERAPEUTICS INC | $39,297,000 | – | 557,095 | +100.0% | 3.67% | – |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $37,299,000 | -42.2% | 1,401,703 | -59.6% | 3.48% | -55.7% |
| ARVN | New | ARVINAS INC | $36,095,000 | – | 425,000 | +100.0% | 3.37% | – |
| KDMN | Sell | KADMON HLDGS INC | $30,501,000 | -44.5% | 7,349,621 | -47.5% | 2.85% | -57.4% |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $27,660,000 | – | 484,671 | +100.0% | 2.58% | – |
| GMDA | New | GAMIDA CELL LTD | $27,584,000 | – | 3,287,745 | +100.0% | 2.58% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $27,351,000 | – | 631,215 | +100.0% | 2.55% | – |
| IMGN | New | IMMUNOGEN INC | $22,678,000 | – | 3,515,944 | +100.0% | 2.12% | – |
| CASI | Buy | CASI PHARMACEUTICALS INC | $22,350,000 | +122.7% | 7,576,431 | +15.5% | 2.09% | +70.6% |
| VSTM | New | VERASTEM INC | $16,572,000 | – | 7,780,186 | +100.0% | 1.55% | – |
| ISEE | Sell | IVERIC BIO INC | $16,404,000 | -24.4% | 2,373,924 | -38.3% | 1.53% | -42.0% |
| STXS | STEREOTAXIS INC | $15,958,000 | +42.2% | 3,135,176 | 0.0% | 1.49% | +9.0% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $11,918,000 | -63.2% | 1,969,875 | 0.0% | 1.11% | -71.8% | |
| CHFWU | New | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $10,470,000 | – | 1,000,000 | +100.0% | 0.98% | – |
| RCUS | New | ARCUS BIOSCIENCES INC | $10,059,000 | – | 387,492 | +100.0% | 0.94% | – |
| SIOX | New | SIO GENE THERAPIES INC | $8,858,000 | – | 3,186,335 | +100.0% | 0.83% | – |
| CLRB | New | CELLECTAR BIOSCIENCES INC | $8,474,000 | – | 4,074,074 | +100.0% | 0.79% | – |
| CTIC | New | CTI BIOPHARMA CORP | $8,091,000 | – | 2,512,800 | +100.0% | 0.76% | – |
| COGT | New | COGENT BIOSCIENCES INC | $6,850,000 | – | 610,000 | +100.0% | 0.64% | – |
| DFHTU | DEERFIELD HEALTHCARE TECH ACunit 07/16/2025 | $3,750,000 | +41.1% | 250,000 | 0.0% | 0.35% | +8.0% | |
| JYAC | New | JIYA ACQUISITION CORP | $3,090,000 | – | 300,000 | +100.0% | 0.29% | – |
| ADMA | ADMA BIOLOGICS INC | $3,039,000 | -18.4% | 1,558,290 | 0.0% | 0.28% | -37.4% | |
| BCTG | BCTG ACQUISITION CORP | $2,059,000 | +10.4% | 180,000 | 0.0% | 0.19% | -15.4% | |
| HLXA | New | HELIX ACQUISITION CORP | $1,685,000 | – | 150,000 | +100.0% | 0.16% | – |
| FSDC | FS DEV CORP | $1,100,000 | -1.8% | 100,000 | 0.0% | 0.10% | -24.3% | |
| ATNM | Sell | ACTINIUM PHARMACEUTICALS INC | $690,000 | -91.0% | 88,428 | -88.9% | 0.06% | -93.2% |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $658,000 | – | 39,697 | +100.0% | 0.06% | – |
| YMAB | New | Y-MABS THERAPEUTICS INC | $301,000 | – | 6,073 | +100.0% | 0.03% | – |
| OMER | Exit | OMEROS CORP | $0 | – | -484,042 | -100.0% | -0.60% | – |
| SLNO | Exit | SOLENO THERAPEUTICS INC | $0 | – | -3,040,000 | -100.0% | -0.93% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -3,236,335 | -100.0% | -1.82% | – |
| MTEM | Exit | MOLECULAR TEMPLATES INC | $0 | – | -1,736,012 | -100.0% | -2.31% | – |
| HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -2,005,218 | -100.0% | -3.62% | – |
| LMNL | Exit | LIMINAL BIOSCIENCES INC | $0 | – | -3,084,627 | -100.0% | -4.18% | – |
| APRE | Exit | APREA THERAPEUTICS INC | $0 | – | -1,459,411 | -100.0% | -4.28% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -2,374,392 | -100.0% | -4.43% | – |
| CGEN | Exit | COMPUGEN LTDord | $0 | – | -2,637,421 | -100.0% | -5.22% | – |
| Exit | APTOSE BIOSCIENCES INC | $0 | – | -7,994,904 | -100.0% | -5.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL | 29 | Q2 2022 | 15.9% |
| ADMA BIOLOGICS INC | 27 | Q4 2020 | 2.3% |
| RETROPHIN INC | 23 | Q1 2020 | 11.3% |
| ANI PHARMACEUTICALS INC | 23 | Q3 2019 | 7.9% |
| VERICEL CORP | 21 | Q4 2019 | 5.5% |
| AMARIN CORP PLC | 14 | Q3 2019 | 14.4% |
| GLOBUS MED INC | 13 | Q2 2022 | 24.7% |
| ORTHOFIX INTL N V | 13 | Q3 2016 | 9.7% |
| PACIFIC BIOSCIENCES CALIF IN | 13 | Q4 2018 | 9.7% |
| CATALYST PHARM PARTNERS INC | 13 | Q3 2019 | 9.4% |
View Consonance Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | December 15, 2022 | 0 | 0.0% |
| ADMA BIOLOGICS, INC. | February 14, 2022 | 1,289,481 | 1.4% |
| ASSEMBLY BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| CASI Pharmaceuticals, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Cellectar Biosciences, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Gamida Cell Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| GenMark Diagnostics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Protagonist Therapeutics, IncSold out | February 14, 2022 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Consonance-HFW Acquisition Corp. | April 27, 2021 | 1,000,000 | 10.4% |
View Consonance Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2022-12-15 |
| SC 13D/A | 2022-12-15 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
View Consonance Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.